Work

Phase II study of erlotinib in recurrent GBM: Molecular predictors of outcome

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.1507

Authors: T. Cloughesy, A. Yung, J. Vrendenberg, K. Aldape, D. Eberhard, M. Prados, S. Vandenberg, B. Klencke, P. Mischel

Institutions: University of California, Los Angeles, Duke University, University of California, San Francisco, Genentech

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2250013128

Cites:

Cited by: 38

Related to: 10